+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sangamo Therapeutics Inc - logo

Sangamo BioSciences is a biotechnology company that develops industry leading technologies in gene therapy, genome editing, cell therapy and gene regulation. The company is focused on pioneering genetic cures for monogenic and infectious diseases by deploying its AAV-based gene therapy platform, and therapeutic genome editing and gene regulation platforms based on its novel zinc finger DNA-binding protein technology. Sangamo is headquartered in Richmond, California.

Hemophilia Market Report 2025 - Product Thumbnail Image

Hemophilia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
Hemophilia- Pipeline Insight, 2025 - Product Thumbnail Image

Hemophilia- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 250 Pages
  • Global
From
Beta-thalassemia- Pipeline Insight, 2025 - Product Thumbnail Image

Beta-thalassemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Thalassemia- Pipeline Insight, 2025 - Product Thumbnail Image

Thalassemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
From
From
From
CAR T-cell Therapy Market 2025-2029 - Product Thumbnail Image

CAR T-cell Therapy Market 2025-2029

  • Report
  • January 2025
  • 199 Pages
  • Global
From
From
Encephalitis Treatment Market Report 2025 - Product Thumbnail Image

Encephalitis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Loading Indicator